Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers
NCT04849559 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2024-04-16
Summary
To evaluate the effects of tradipitant relative to placebo on satiation, gastric volume, gastric accommodation, and gastric emptying in healthy volunteers.
Conditions
- Healthy Volunteer
Interventions
- DRUG
-
Tradipitant Capsule
- DRUG
-
Placebo Capsule
Sponsors & Collaborators
- collaborator OTHER
- lead INDUSTRY
Principal Investigators
-
Vanda Pharmaceuticals · Vanda Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2021-09-24
- Completion
- 2021-09-24
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers
NCT01267071 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults
NCT03718390 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers
NCT03565861 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects
NCT04183686 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study of Oral Vadadustat in Subjects With Normal and Impaired Hepatic Function
NCT03799848 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery Patients
NCT03070509 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Investigate the Effect of Esomeprazole and the Effect of Food on the Pharmacokinetics of Balovaptan in Healthy Volunteers
NCT04156646 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers
NCT02259842 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Bioactive Peptides' Effect on Digestive Discomfort Symptoms of the Elderly
NCT04450979 ·Status: COMPLETED ·Phase: NA
-
Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat
NCT04299633 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects
NCT02770404 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants
NCT06887010 ·Status: COMPLETED ·Phase: PHASE1
-
Gut Transit Effect on Enterohepatic Circulation
NCT03501498 ·Status: COMPLETED ·Phase: NA
-
Safety of Larazotide Acetate in Healthy Volunteers
NCT00386490 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, Explore the Effect of Food After Multiple Doses of Selected Prototypes, and Evaluate Alternative Formulations of KarX and KarXT Following Single and Multiple Ascending Doses
NCT07063342 ·Status: RECRUITING ·Phase: PHASE1
-
A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function
NCT06938529 ·Status: COMPLETED ·Phase: PHASE1
-
Study of NST-6179 in Healthy Subjects
NCT05181085 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects
NCT02225626 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248
NCT04617509 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2
NCT03802526 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949
NCT02099071 ·Status: COMPLETED ·Phase: PHASE1
-
An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
NCT01848340 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers
NCT01080820 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Safety and Pharmacokinetics of Oral Controlled-ileal-release Nicotinic Acid (CIR-NA) Compared to Immediate-release Nicotinic Acid and Placebo in Healthy Subjects and Subjects With Prediabetes
NCT06378125 ·Status: COMPLETED ·Phase: PHASE1
-
An Early Clinical Trial to Evaluate VGN-R09b for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency.
NCT05765981 ·Status: RECRUITING ·Phase: EARLY_PHASE1